Direkt zum Inhalt
Merck
Alle Fotos(1)

Wichtige Dokumente

Gesamtdokumentation anzeigen

1134335

USP

Ciprofloxacinhydrochlorid

United States Pharmacopeia (USP) Reference Standard

Synonym(e):

Ciprofloxacin -hydrochlorid Monohydrat

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C17H18FN3O3 · HCl · H2O
CAS-Nummer:
86393-32-0
Molekulargewicht:
385.82
MDL-Nummer:
MFCD00242856
UNSPSC-Code:
41116107
PubChem Substanz-ID:
329749408
NACRES:
NA.24

Qualität

pharmaceutical primary standard

API-Familie

ciprofloxacin

Hersteller/Markenname

USP

Anwendung(en)

pharmaceutical (small molecule)

Format

neat

SMILES String

O.Cl.OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O

InChI

1S/C17H18FN3O3.ClH.H2O/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24;;/h7-10,19H,1-6H2,(H,23,24);1H;1H2

InChIKey

ARPUHYJMCVWYCZ-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Ähnliches Produkt

Produkt-Nr.
Beschreibung
Preisangaben

PHR1167

Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material

PHR1174

Fluorchinolonsäure, Pharmaceutical Secondary Standard; Certified Reference Material

1134324

Ciprofloxacin-Ethylendiamin-Analogon, United States Pharmacopeia (USP) Reference Standard

1278302

Fluorchinolonsäure, United States Pharmacopeia (USP) Reference Standard

C2190000

Ciprofloxacin-Hydrochlorid, European Pharmacopoeia (EP) Reference Standard

Y0000198

Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard

Y0000199

Ciprofloxacinhydrochlorid für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard

C2190050

Ciprofloxacin-Unreinheit A, European Pharmacopoeia (EP) Reference Standard

1134459

Ciprofloxacin formamide, United States Pharmacopeia (USP) Reference Standard

1134346

Ciprofloxacin-verwandte Verbindung A, United States Pharmacopeia (USP) Reference Standard

1134313

Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard

BP930

Ciprofloxacin-Unreinheit Standard, British Pharmacopoeia (BP) Reference Standard

BP929

Ciprofloxacin -hydrochlorid, British Pharmacopoeia (BP) Reference Standard

PHR2440

Ciprofloxacin-Formamid, certified reference material, pharmaceutical secondary standard

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 2

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Andrea Meyerhoff et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 39(3), 303-308 (2004-08-13)
In August 2000, the US Food and Drug Administration (FDA) approved ciprofloxacin hydrochloride (Cipro; Bayer) for management of postexposure inhalational anthrax. This was the first antimicrobial drug approved by the FDA for use in treating an infection due to a
Lucile Pantel et al.
Antimicrobial agents and chemotherapy (2021-03-10)
NOSO-502 is a preclinical antibiotic candidate of the Odilorhabdin class. This compound exhibits activity against Enterobacteriaceae pathogens, including carbapenemase-producing bacteria and most of the Colistin (CST)-resistant strains. Among a collection of CST-resistant Klebsiella pneumoniae strains harboring mutations on genes pmrAB
Tarek Haddad et al.
Chemosphere, 115, 40-46 (2014-03-19)
The presence of pharmaceuticals, especially antibiotics, in the aquatic environment is of growing concern. Several studies have been carried out on the occurrence and environmental risk of these compounds. Ciprofloxacin (CIP), a broad-spectrum anti-microbial second-generation fluoroquinolone, is widely used in
Corinne N Thompson et al.
Tropical medicine & international health : TM & IH, 19(10), 1284-1292 (2014-07-30)
The country of Fiji, with a population of approximately 870 000 people, faces a growing burden of several communicable diseases including the bacterial infection typhoid fever. Surveillance data suggest that typhoid has become increasingly common in rural areas of Fiji
Juliann G Kiang et al.
Health physics, 106(6), 720-726 (2014-04-30)
Exposure to ionizing radiation alone (radiation injury, RI) or combined with traumatic tissue injury (radiation combined injury, CI) is a crucial life-threatening factor in nuclear and radiological accidents. It is well documented that RI and CI occur at the molecular
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.